Trial · NCT05355337
Registered outcomes45
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 45
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Effect on anhedonia symptoms | 9 weeks | Change in Snaith-Hamilton Pleasure Scale (SHAPS) self-report total score from baseline to week 9. Higher scores equal more severe anhedonoa. Score range 14-56 |
| Secondary | Effect on core depression symptoms | 9 weeks | Change in Hamilton Rating Scale for Depression 6 items (HDRS-6) total score baseline to week 9 |
| Secondary | Effect on other anhedonic domains not measured by SHAPS | 9 weeks | Change in Dimensional Anhedonia Rating Scale (DARS) total score (inverse scale, lower points equals more anhedonia) from baseline to week 9 |
| Secondary | Effect on general depressive symptoms | 9 weeks | Change in Montgomery-Åsberg Depression Rating Scale (MADRS-S) total score from baseline to week 9 |
| Secondary | Effect on sleep disturbances | 9 weeks | Change in Insomnia Severity Index (ISI) total score from baseline to week 9 |
| Secondary | Effect on apathy symptoms | 9 weeks | Change in Apathy Evaluation Scale (AES) total score from baseline to week 9 |
| Secondary | Effect on anxiety symptoms | 9 weeks | Change in Generalized Anxiety Disorder 7-item scale (GAD-7) total score from baseline to week 9 |
| Secondary | Effect on quality of life | 9 weeks | Change in Brunnsviken Brief Quality of life scale (BBQ) total score from baseline to week 9 |
| Secondary | Effect on number of steps | 9 weeks | Change in parameter "number of steps" measured with a digital activity monitor (accelerometry bracelet), from baseline to week 9 |
| Secondary | Effect on distance travelled | 9 weeks | Change in parameter "distance travelled" measured with a digital activity monitor (accelerometry bracelet), from baseline to week 9 |
| Secondary | Effect on distribution of movement pattern over the day | 9 weeks | Change in parameter "distribution of movement pattern over the day" measured with a digital activity monitor (accelerometry bracelet), from baseline to week 9 |
| Secondary | Effect on sedantary behaviour | 9 weeks | Change in parameter "sedentary behaviour" measured with a digital activity monitor (accelerometry bracelet), from baseline to week 9 |
| Secondary | Effect on time spent in light | 9 weeks | Change in parameter "time spent in light" measured with a digital activity monitor (accelerometry bracelet), from baseline to week 9 |
| Secondary | Effect on moderate and vigorous physical activity | 9 weeks | Change in parameter "moderate and vigorous physical activity" measured with a digital activity monitor (accelerometry bracelet), from baseline to week 9 |
| Secondary | Effect on sleep latency | 9 weeks | Change in parameter sleep latency (= time to fall asleep) using a digital activity monitor (accelerometry bracelet), from baseline to week 9 |
| Secondary | Effect on sleep awakening | 9 weeks | Change in parameter sleep awakening (= how often one wakes up during the night) using a digital activity monitor (accelerometry bracelet), from baseline to week 9 |
| Secondary | Effect on wakefulness | 9 weeks | Change in parameter wakefulness (=time in minutes awake during one night) using a digital activity monitor (accelerometry bracelet), from baseline to week 9 |
| Secondary | Effect on time in deep sleep | 9 weeks | Change in parameter "time in deep sleep" using a digital activity monitor (accelerometry bracelet), from baseline to week 9 |
| Secondary | Effect on movement during sleep cycles | 9 weeks | Change in parameter "movement during sleep cycles" using a digital activity monitor (accelerometry bracelet), from baseline to week 9 |
| Secondary | Effect on sleep efficiency | 9 weeks | Change in parameter sleep efficiency (=sleep time vs total time spent in bed) using a digital activity monitor (accelerometry bracelet), from baseline to week 9 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05355337/registered